FBIO חוב לטווח קצר להון עצמי Fortress Biotech

The stock price trend for Fortress Biotech, Inc. (FBIO) on the GURU.Markets platform, recorded at 0.02, confirms the company's status as a skilled creator of biopharma projects that has earned the market's trust. Broad patent coverage and complex FDA certification provide a defensive moat for the business. The holding company's success is based on its ability to identify promising developments and profitably realize them following registration or sale to industry behemoths.

This indicator assesses the proportion of short-term liabilities within the equity structure, signaling the risk of cash flow gaps in the event of a sharp increase in debt load. By analyzing the short-term debt-to-market cap chart, an investor can evaluate the financial stability of Fortress Biotech, Inc. (FBIO), whose holding model for asset distribution among subsidiaries is designed to minimize operational risks during the development of various medical drugs.